Search Videos and More
Symposium
2021 SABCS Highlights
Dana-Farber Cancer Institute faculty highlights from the 2021 San Antonio Breast Cancer Symposium.
Video
Blood Cancer Research: Clinical Trial Helps Younger Patient
A patient shares her journey getting diagnosed with chronic lymphocytic leukemia in her 30's. Dana-Farber Cancer Institute's Matthew Davids, MD, MMSc, enrolled her on a clinical trial and details the results of that study. The research is now getting presented at ASH21.
Video
Inadequate SARS-COV-2 Vaccine Effectiveness in Patients with Multiple Myeloma: A Large Nationwide Veterans Affairs Study
Dana-Farber Cancer Institute's Nikhil C. Munshi, MD, details study looking at COVID-19 vaccine effectiveness in patients with multiple myeloma. Research presented at ASH21.
News
ASH 2021 Highlights - CME
Register for 2021 ASH Highlights CME
Video
New Study Reveals Elevated Rates of Blood Cancer Precursor Condition in Groups at High Risk for Multiple Myeloma
Dana-Farber Cancer Institute research shows elevated rates of a blood cancer precursor condition in groups at high risk for multiple myeloma.
News
American Society of Hematology (ASH) Annual Meeting
As leaders in blood and blood cancer research, physicians and scientists from Dana-Farber Cancer Institute shared advances and insights at the 63rd Annual Meeting of the American Society of Hematology (ASH) on December 11–14, 2021 in Atlanta, Georgia
News
New Study Reveals Elevated Rates of Blood Cancer Precursor Condition in Groups at High Risk for Multiple Myeloma
The first results from the largest screening study yet conducted in the United States of individuals at above-average risk for the blood cancer multiple myeloma have revealed higher rates of a myeloma precursor condition in older adults who are Black or who have a close family member with a current or past blood cancer.
Video
Adjuvant Palbociclib in HR+/HER2 Early Breast Cancer - Final results from PALLAS Trial
Dana-Farber's Erica Mayer, MD, MPH discusses the final analysis of the International Phase 3 PALLAS clinical trial presented at the 2021 San Antonio Breast Cancer Symposium.
Video
GS2-05 Update on the Combined TEXT and SOFT Trials
Dana-Farber's Meredith Regan, ScD presented an update on the SOFT/TEXT clinical trials at the 2021 San Antonio Breast Cancer Symposium.
News
Dana-Farber Researchers Present Findings at San Antonio Breast Cancer Symposium
Researchers from Dana-Farber Cancer Institute will present more than 30 research studies at the 44th annual San Antonio Breast Cancer Symposium on December 7-10th.
Document
ASH 2021 Featured Oral Presentations
The Annual Meeting of the American Society of Hematology (ASH) will take place December 11-14th. To keep-up with latest advances, the live schedule of oral presentations by Dana-Farber faculty is attached for your convenience.
News
2021 ASCO Highlights
Dana-Farber physician-scientists shared research and clinical advances at the 2021 Annual Meeting of the American Society of Clinical Oncologists (ASCO).